SAN DIEGO, CA -- (MARKET WIRE) -- April 03, 2007 -- Aegis Therapeutics, a leader in intranasal drug delivery, will present a talk entitled: “High-Efficiency Delivery of Peptides, Proteins, and Other Macromolecules via Intranasal & Other Transmucosal Routes” at the Arrowhead “Drug Delivery 2007 Conference”. The conference will be held on April 10, 2007 at the Crown Plaza Union Square, San Francisco. Dr. Edward T. Maggio, President and CEO of Aegis, will describe the application of Aegis’ Intravail® non-invasive drug delivery technology, and Aegis’ ProTek® protein stabilization technology to specific peptide and protein therapeutics.
